Company news

PTC Therapeutics, Inc. news in 2021

PTC Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Oral Splicing Modifiers that Systemically Lower Huntington Disease Protein Discovered Through PTC Therapeutics' Innovative Splicing Platform

December 19, 2021

Evrysdi® Distinguished by Two Prestigious Awards for Outstanding Innovation in Drug Discovery

December 5, 2021

PTC Therapeutics to Participate at Upcoming Virtual Investor Conference

November 15, 2021

PTC Therapeutics Provides a Corporate Update and Reports Third Quarter 2021 Financial Results

October 27, 2021

PTC Announces Expansion of Translarna™ Label to Include Ambulatory Patients as Young as 2 Years Old in Brazil

October 24, 2021

PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2021 Financial Results

October 13, 2021

PTC Therapeutics Celebrates Opening of Gene Therapy Manufacturing Facility

October 13, 2021

Tegsedi® Receives Innovative Drug Category Pricing in Brazil

October 10, 2021

Results Show Long-Lasting and Holistic Improvements in Children with AADC Deficiency Treated with PTC-AADC Gene Therapy

September 28, 2021

STRIDE Data Show Translarna™ Delays Loss of Ambulation by More Than Five Years in Boys with Nonsense Mutation Duchenne Muscular Dystrophy

September 19, 2021

PTC Therapeutics to Host Conference Call to Discuss Results of PTC518 Phase 1 Study for Huntington's Disease Program

September 19, 2021

PTC Therapeutics Recognizes 2021 STRIVE Awards Recipients for Initiatives Supporting Duchenne Patient Community

September 6, 2021

PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences

August 26, 2021

PTC Therapeutics Announces Waylivra™ Approval in Brazil as First Treatment for Familial Chylomicronemia Syndrome

August 22, 2021

PTC Therapeutics Provides a Corporate Update and Reports Second Quarter 2021 Financial Results

July 28, 2021

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2021 Financial Results

July 14, 2021

Results Add to Body of Evidence Confirming EMFLAZA®'s Benefit Over Prednisone

June 23, 2021

Evrysdi™ Approved in Japan for the Treatment of Spinal Muscular Atrophy

June 22, 2021

Health and Human Services Expert Mary L. Smith Joins PTC Therapeutics' Board of Directors

June 8, 2021

PTC Therapeutics Announces Orphan Drug Designations of PTC923 for the Treatment of Hyperphenylalaninemia

May 25, 2021

New Data Shows Devastating Impact of AADC Deficiency on Caregivers

May 16, 2021

PTC Therapeutics Provides a Corporate Update and Reports First Quarter 2021 Financial Results

May 3, 2021

PTC Therapeutics to Host Conference Call to Discuss First Quarter 2021 Financial Results

April 19, 2021

PTC Therapeutics Launches the PTC Pinpoint Direct™ Program for Patient-Initiated Genetic Testing

April 13, 2021

PTC Therapeutics to Host PTC518 Huntington Disease Deep Dive Webinar

April 6, 2021

PTC Therapeutics Received Gallup's "Don Clifton Strengths-Based Culture" Award

April 6, 2021

PTC Therapeutics Announces Commercial Milestone Payment Following the Recent European Approval of Evrysdi™

March 31, 2021

PTC Therapeutics Announces the European Approval of Evrysdi™ for the Treatment of Spinal Muscular Atrophy

March 29, 2021

PTC Presents Results from a Real-World Study of Steroid Switching in the Treatment of Patients with Dystrophinopathies

March 14, 2021

Spinal Muscular Atrophy (SMA) Foundation and PTC Therapeutics Expand Partnership to Advance Drug Discovery and Development Research in Regenerative Medicine

March 8, 2021

PTC Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

February 24, 2021

PTC Therapeutics Reports the Initiation of the Second Stage of the FITE19 Phase 2/3 Clinical Trial Evaluating PTC299 for the Treatment of COVID-19

February 16, 2021

PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results

February 10, 2021

PTC Therapeutics Opens Applications for the Annual STRIVE Awards Program and Introduces a New Award Category

January 13, 2021

Calls in 2021

Decks in 2021